Single oligoarray-based detection of specific M918T mutation in RET oncogene in multiple endocrine neoplasia type 2B

被引:0
|
作者
Pacheco-Rivera, R. A. [2 ,7 ]
Hernandez-Zamora, E. [1 ]
Gonzalez-Yebra, B. [3 ]
Beattie, K. [4 ]
Maldonado-Rodriguez, R. [5 ]
Santiago-Hernandez, J. C. [5 ]
Medrano-Ortiz de Zarate, M. E. [6 ]
Salcedo, M. [7 ]
机构
[1] Inst Nacl Rehabil, Serv Genet, Mexico City, DF, Mexico
[2] ENCB IPN, Lab Diagnost Mol, Mexico City, DF, Mexico
[3] Univ Guanajuato, Dept Biol Mol, Guanajuato, Mexico
[4] Oak Ridge Natl Lab, Div Life Sci, Oak Ridge, TN USA
[5] ENCB IPN, Lab Biotecnol & Bioinformat Mol, Mexico City, DF, Mexico
[6] Hosp Oncol, CMN SXXI IMSS, Serv Endocrinol, Mexico City, DF, Mexico
[7] IMSS, UIMEO CMN SXXI, Lab Oncol Genom, Mexico City, DF, Mexico
关键词
Oligoarray; Mutation; MEN; 2B; RET; MEDULLARY-THYROID CARCINOMA; DNA MICROARRAYS; CODON; 634; PROTOONCOGENE; DISEASE; CANCER; HYBRIDIZATION; MANAGEMENT; FAMILIES;
D O I
10.1007/s10238-010-0128-z
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The most important mutation associated with Multiple Endocrine Neoplasia type 2B (MEN 2B) is the change of thymine to cytosine in codon 918 of exon 16 in the RET oncogene (ATG -> ACG). The aim of this work was to develop a single oligoarray by using tandem hybridization to detect the T918C/RET mutation for MEN 2B patients. Two genetically non-related families were studied; each family had a member affected by MEN2B. Both patients presented the T918C/RET mutation in a heterozygous fashion. None of the relatives was positive for this mutation; thus, these cases arose de novo. The proper mutation was confirmed by with different tools, PCR-Fok I endonuclease, direct sequencing, and also using our oligoarray. In this case, it is suitable to use a DNA target smaller than 150 bases with single-or double-stranded DNA and short probes of 7-mer. It was also possible to detect the mutation by employing different sources of DNA, fresh or paraffin-embedded tissues. Therefore, the present oligoarray can identify the most common M918T mutation of RET oncogene from a variety of DNA sources with good specificity and be a good alternative in the molecular diagnosis for MEN 2B cases.
引用
收藏
页码:227 / 234
页数:8
相关论文
共 50 条
  • [31] A two-hit model for development of multiple endocrine neoplasia type 2B by RET mutations
    Iwashita, T
    Murakami, H
    Kurokawa, K
    Kawai, K
    Miyauchi, A
    Futami, H
    Qiao, S
    Ichihara, M
    Takahashi, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 268 (03) : 804 - 808
  • [32] Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation
    Kawai, K
    Iwashita, T
    Murakami, H
    Hiraiwa, N
    Yoshiki, A
    Kusakabe, M
    Ono, K
    Iida, K
    Nakayama, A
    Takahashi, M
    CANCER RESEARCH, 2000, 60 (18) : 5254 - 5260
  • [33] GERM-LINE MUTATION IN THE RET PROTOONCOGENE ASSOCIATED WITH FAMILIAL MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B - A CASE-REPORT
    ISHIDA, O
    ZEKI, K
    MORIMOTO, I
    YAMAMOTO, S
    FUJIHIRA, T
    ETO, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1995, 25 (03) : 104 - 108
  • [34] POINT MUTATION WITHIN THE TYROSINE KINASE DOMAIN OF THE RET PROTOONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B AND RELATED SPORADIC TUMORS
    ENG, C
    SMITH, DP
    MULLIGAN, LM
    NAGAI, MA
    HEALEY, CS
    PONDER, MA
    GARDNER, E
    SCHEUMANN, GFW
    JACKSON, CE
    TUNNACLIFFE, A
    PONDER, BAJ
    HUMAN MOLECULAR GENETICS, 1994, 3 (02) : 237 - 241
  • [35] Molecular diagnosis of multiple endocrine neoplasia (MEN) type 2A: Implementation of mutation detection in RET oncogene and challenges in the management of affected individuals
    Radian, S.
    Badiu, C.
    Capatina, Cristina
    Coculescu, M.
    Grigorescu, F.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2007, 3 (01) : 13 - 22
  • [36] A family of multiple endocrine neoplasia type 2A with the RET proto-oncogene mutation in codon 618 (Cys→Arg)
    Nakao, A
    Naomoto, Y
    Kataoka, M
    Haisa, M
    Kataoka, K
    Saitoh, S
    Fujiwara, T
    Yamatsuji, T
    Shigemitsu, K
    Umeoka, T
    Isozaki, H
    Futami, H
    Yamaguchi, K
    Tanaka, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (04) : 157 - 161
  • [37] Genetic testing for familial cancer - Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2
    Learoyd, DL
    Marsh, DJ
    Richardson, AL
    Twigg, SM
    Delbridge, L
    Robinson, BG
    ARCHIVES OF SURGERY, 1997, 132 (09) : 1022 - 1025
  • [38] Germline RET V804M mutation associated with multiple endocrine neoplasia type 2A
    Gibelin, H
    Bezieau, S
    Misso, C
    Bouin-Pineau, MH
    Maréchaud, R
    Kraimps, JL
    BRITISH JOURNAL OF SURGERY, 2004, 91 (11) : 1458 - 1459
  • [39] Multiple Endocrine Neoplasia 2B Syndrome due to Codon 918 Mutation: Clinical Manifestation and Course in Early and Late Onset Disease
    Michael Brauckhoff
    Oliver Gimm
    Carl-Ludwig Weiss
    Jörg Ukkat
    Carsten Sekulla
    Katrin Brauckhoff
    Phuong Nguyen Thanh
    Henning Dralle
    World Journal of Surgery, 2004, 28 : 1305 - 1311
  • [40] Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: Clinical manifestation and course in early and late onset disease
    Brauckhoff, M
    Gimm, O
    Weiss, CL
    Ukkat, J
    Sekulla, C
    Brauckhoff, K
    Thanh, PN
    Dralle, H
    WORLD JOURNAL OF SURGERY, 2004, 28 (12) : 1305 - 1311